Answers are grounded in this paper and cite their sources.
One hundred years after insulin became commercially available, new formulations are still being developed. A first once-weekly insulin has been introduced on various markets, and results of the registration studies of a second once-weekly insulin are becoming available. In this narrative review, we discuss the mechanisms of prolongation, early clinical research study results, and the registration studies of these insulins, with a critical appraisal.
No takes yet. Share an insight, caveat, or question.
J. Hans DeVries (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: